GANZIMMUN Diagnostics GmbH celebrates topping-out ceremony on Mainz Lerchenberg.
Mainz, January 11, 2023
The previously based in Mainz Bretzenheim company GANZIMMUN Diagnostics GmbH is expanding. The new location is currently being built on the Lerchenberg. After laying the foundation stone in July 2022, the topping-out ceremony could now be celebrated.
On the 8,000 m² plot, 7,500 m² of space will be created for laboratory, office, and practice rooms. The project is being realized by KPE Projekt Lerchenberg GmbH, in which Karrié Projektentwicklung GmbH & Co. KG is involved in cooperation with Rahlfs Immobilien GmbH. The project is scheduled for completion in 2024.
Further settlements from the life science sector are planned in the immediate vicinity. "The biotech and life science sector is booming. Companies that are already based in Mainz and want to expand or want to settle here need adequate offers, otherwise they will move away or choose another location. The Lerchenberg area has the potential for another 75,000 m² of gross floor space for new settlements".
Dr. med. Patrik Zickgraf, CEO and medical director of GANZIMMUN Diagnostics GmbH, sees his decision for the new location confirmed: "We already benefit today from the proximity to biotechnology companies such as BioNTech, Böhringer, Merck and BASF. It is all the more important that actions follow the words to expand Mainz as a biotechnology and medical technology hub. With a view to optimal transport links and the already planned and existing infrastructure, the Lerchenberg area can contribute to this."
